Search
Vaxelis; hexavalent vaccine (DTaP-IPV-Hib-HepB)
Indications:
hexavalent vaccine for immunization against
- diphtheria
- tetanus
- pertussis
- poliomyelitis
- hepatitis B
- Haemophilus influenzae type b
children aged 6 weeks-4 years
Dosage:
- 3-dose series at ages 2, 4, & 6 months
additional dose of pertussis vaccine required
Notes:
- not be available until 2020
General
vaccine
References
- Sanofi Press Release December 26, 2018
FDA Approves VAXELIS Sanofi and MSD's Pediatric Hexavalent
Combination Vaccine.
http://hugin.info/152918/R/2230064/876179.pdf
- Oliver SE, Moore KL.
Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis,
Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate,
and Hepatitis B Vaccine, and Guidance for Use in Infants.
MMWR Morb Mortal Wkly Rep 2020;69:136-139
PMID: 32027629 Free full text
https://www.cdc.gov/mmwr/volumes/69/wr/mm6905a5.htm